KANG [iKang Healthcare] 6-K: EXECUTION VERSION AMENDMENT NO. 3 TO RIGHTS AGREEMENT

Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 6-K, Date: 2018-03-28
Original SEC Filing: Click here


Webplus: KANG/20180328/6-K/2_EX-4.1/000.htm SEC Original: a18-9127_1ex4d1.htm
EXECUTION VERSION AMENDMENT NO. 3 TO RIGHTS AGREEMENT Amendment Rights Agreement Company Rights Agent AMENDMENT NO. 3 (this “ WHEREAS, the Board of Directors desires to amend the Rights Agreement as set forth herein; WHEREAS, the Flip-In Date has not occurred; WHEREAS, the Special Committee has approved this Amendment; and NOW, THEREFORE, in consideration of the foregoing and the mutual




Webplus: KANG/20180328/6-K/3_EX-99.1/000.htm SEC Original: a18-9127_1ex99d1.htm
Execution Version AGREEMENT AND PLAN OF MERGER among IK HEALTHCARE INVESTMENT LIMITED, IK HEALTHCARE MERGER LIMITED and IKANG HEALTHCARE GROUP, INC. Dated as of March 26, 2018 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.01 The Merger 7 Section 1.02 Closing; Closing Date 7 Section 1.03 Effective Time 7 Section 1.04 Effects of the Merger 7 Section 1.05




Webplus: KANG/20180328/6-K/1/000.htm SEC Original: a18-9127_16k.htm
IKANG HEALTHCARE GROUP, INC. Yang Chen Chief Financial Officer



Company Info:

Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 6-K, Date: 2018-03-28CIK: 0001524190, Location: F4, SIC: 8011, SIC Desc: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Business Phone & Address:
B-6F, SHIMAO TOWER, 92A JIANGUO ROAD, CHAOYANG DISTRICT
Beijing 100022

Home Page Forums

About the Author:

Leave A Comment

Skip to toolbar